{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:10:38Z","timestamp":1790975438486,"version":"4.1.0"},"reference-count":271,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1378\/chest.08-0665","type":"journal-article","created":{"date-parts":[[2008,6,23]],"date-time":"2008-06-23T23:37:53Z","timestamp":1214264273000},"page":"708S-775S","source":"Crossref","is-referenced-by-count":83,"special_numbering":"S","title":["Acute ST-Segment Elevation Myocardial Infarction"],"prefix":"10.1016","volume":"133","author":[{"given":"Shaun G.","family":"Goodman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venu","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.08-0665_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(03)12712-2","article-title":"Acute myocardial infarction","volume":"361","author":"Boersma","year":"2003","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib2","first-page":"349","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0735-1097(03)00919-7","article-title":"Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty","volume":"42","author":"De Luca","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.CIR.0000121424.76486.20","article-title":"Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts","volume":"109","author":"De Luca","year":"2004","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib5","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.0000126892.17646.83","article-title":"Treatment delayed is treatment denied","volume":"109","author":"Williams","year":"2004","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib6","author":"Antman"},{"key":"10.1378\/chest.08-0665_bib7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1997.03550230069040","article-title":"Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review","volume":"278","author":"Weaver","year":"1997","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1067\/mhj.2003.40","volume":"145","year":"2003","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1056\/NEJM199303113281002","article-title":"A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction","volume":"328","author":"Zijlstra","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199303113281001","article-title":"A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction","volume":"328","author":"Grines","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199303113281003","article-title":"Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction","volume":"328","author":"Gibbons","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib13","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJM199912233412601","article-title":"Coronary angioplasty with or without stent implantation for acute myocardial infarction","volume":"341","author":"Grines","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0735-1097(98)00622-6","article-title":"Long-term outcome after primary angioplasty: report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) trial","volume":"33","author":"Nunn","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib16","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199911043411901","article-title":"Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction","volume":"341","author":"Zijlstra","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib17","first-page":"1133","article-title":"Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study)","volume":"19","author":"Bednar","year":"2003","journal-title":"Can J Cardiol"},{"key":"10.1378\/chest.08-0665_bib18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0002-9149(03)00891-9","article-title":"Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?","volume":"92","author":"Nallamothu","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/eurheartj\/ehi810","volume":"27","author":"Boersma","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.CIR.0000155258.44268.F8","article-title":"Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3\/4 analysis","volume":"111","author":"Nallamothu","year":"2005","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib21","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM200005253422106","article-title":"The volume of primary angioplasty procedures and survival after acute myocardial infarction","volume":"342","author":"Canto","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib22","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1001\/jama.284.24.3131","article-title":"Relation between hospital primary angioplasty volume and mortality for patients with acute mi treated with primary angioplasty vs thrombolytic therapy","volume":"284","author":"Magid","year":"2000","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib23","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.290.14.1891","article-title":"Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis","volume":"290","author":"Grzybowski","year":"2003","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-115-3-173","article-title":"Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy","volume":"115","author":"Cragg","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0665_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9149(91)90090-8","article-title":"Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy","volume":"67","author":"Brodie","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1522-726X(199902)46:2<127::AID-CCD2>3.0.CO;2-G","article-title":"Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy: maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group","volume":"46","author":"Zahn","year":"1999","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1378\/chest.08-0665_bib27","first-page":"397","volume":"1","year":"1986","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib28","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM198606053142301","volume":"314","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib29","first-page":"545","volume":"1","year":"1988","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(88)92656-6","article-title":"Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: anglo-Scandanavian study of early thrombolysis (ASSET)","volume":"2","author":"Wilcox","year":"1988","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9149(91)90348-O","article-title":"on behalf of Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction","volume":"68","author":"Rossi","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0140-6736(92)91893-D","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0140-6736(93)91539-X","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0140-6736(93)91538-W","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib35","first-page":"65","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0140-6736(90)91590-7","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib38","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199710163371603","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0140-6736(95)92224-5","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib40","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJM199710163371604","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib43","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/01.STR.31.8.1802","article-title":"Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the cooperative cardiovascular project","volume":"31","author":"Brass","year":"2000","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0665_bib44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-125-11-199612010-00004","article-title":"Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction: a randomized trial","volume":"125","author":"Aylward","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0665_bib45","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1161\/01.CIR.101.19.2239","article-title":"Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years","volume":"101","author":"Thiemann","year":"2000","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib46","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0735-1097(00)00723-3","article-title":"Thrombolytic therapy in older patients","volume":"36","author":"Berger","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib47","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0140-6736(00)03397-3","article-title":"Thrombolytic therapy in the elderly","volume":"356","author":"White","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib48","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archinte.163.8.965","article-title":"Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort","volume":"163","author":"Stenestrand","year":"2003","journal-title":"Arch Intern Med"},{"issue":"64(suppl)","key":"10.1378\/chest.08-0665_bib49","doi-asserted-by":"crossref","first-page":"30A","DOI":"10.1016\/0002-9149(89)90927-2","article-title":"Prehospital use of APSAC: results of a placebo-controlled study","author":"Castaigne","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJM199308053290602","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib51","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/bmj.305.6853.548","volume":"305","year":"1992","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0665_bib52","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0735-1097(90)90219-F","article-title":"Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study","volume":"15","author":"Roth","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib53","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0002-9149(90)90528-9","article-title":"Prehospital thrombolysis in acute myocardial infarction","volume":"66","author":"Schofer","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib54","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/jama.1993.03510100061033","article-title":"Prehospital-initiated vs hospital-initiated thrombolytic therapy: the Myocardial Infarction Triage and Intervention Trial","volume":"270","author":"Weaver","year":"1993","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib55","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0002-9149(90)90352-2","article-title":"Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction","volume":"66","author":"Karagounis","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib56","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(02)09963-4","article-title":"Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study","volume":"360","author":"Bonnefoy","year":"2002","journal-title":"Lancet"},{"issue":"20","key":"10.1378\/chest.08-0665_bib57","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1001\/jama.283.20.2686","article-title":"Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis","volume":"283","author":"Morrison","year":"2000","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(94)90494-4","article-title":"Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT)","volume":"23","author":"Rawles","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib59","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/01.CIR.0000103122.10021.F2","article-title":"Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM Randomized Clinical Trial","volume":"108","author":"Steg","year":"2003","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0195-668X(02)00468-2","article-title":"Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial; PRAGUE-2","volume":"24","author":"Widimsky","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0735-1097(02)01936-8","article-title":"Evaluation of the time saved byprehospital initiation of reteplase for ST-elevation myocardial infarction: results of the early retavase-thrombolysisin myocardial infarction (ER-TIMI) 19 trial","volume":"40","author":"Morrow","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.0000081659.72985.A8","volume":"108","author":"Wallentin","year":"2003","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib63","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(96)02514-7","article-title":"Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour","volume":"348","author":"Boersma","year":"1996","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib64","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199602223340801","article-title":"Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block","volume":"334","author":"Sgarbossa","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0735-1097(97)00160-5","article-title":"The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III registry ECG ancillary study","volume":"30","author":"Cannon","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2005.02.084","article-title":"Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes","volume":"46","author":"Wong","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib67","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(01)06887-8","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib68","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/euhj.1999.1748","article-title":"Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction","volume":"21","author":"Menown","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7326\/0003-4819-137-2-200207160-00006","article-title":"Use of the electrocardiograph-based thrombolytic predictive instrument to assist thrombolytic and reperfusion therapy for acute myocardial infarction: a multicenter, randomized, controlled, clinical effectiveness trial","volume":"137","author":"Selker","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0665_bib70","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/0735-1097(88)92594-6","article-title":"A comprehensive analysis of myocardial infarction due to left circumflex artery occlusion: comparison with infarction due to right coronary artery and left anterior descending artery occlusion","volume":"12","author":"Huey","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib71","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0735-1097(97)00538-X","article-title":"Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior myocardial infarction: application for thrombolytic therapy","volume":"31","author":"Matetzky","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib72","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0735-1097(03)01065-9","volume":"42","author":"Cheitlin","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib73","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/01.CIR.98.14.1376","article-title":"Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage","volume":"98","author":"Sloan","year":"1998","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib74","doi-asserted-by":"crossref","first-page":"597","DOI":"10.7326\/0003-4819-129-8-199810150-00002","article-title":"Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction: participants in the National Registry of Myocardial Infarction 2","volume":"129","author":"Gurwitz","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0665_bib75","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(05)80089-3","article-title":"Individual risk assessment for intracranial haemorrhage during thrombolytic therapy","volume":"342","author":"Simoons","year":"1993","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib76","unstructured":"Sloan MA, Guigliano RP, Thompson SL. Prediction of intracranial hemorrhage in the InTIME-II trial. 2001; 372A"},{"key":"10.1378\/chest.08-0665_bib77","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1067\/mhj.2001.114975","article-title":"Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage","volume":"141","author":"Giugliano","year":"2001","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib78","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9343(01)00715-X","article-title":"New heparin dosing recommendations for patients with acute coronary syndromes","volume":"110","author":"Menon","year":"2001","journal-title":"Am J Med"},{"key":"10.1378\/chest.08-0665_bib79","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.CIR.90.4.1624","article-title":"for the TIMI 9A Investigators. Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial","volume":"90","author":"Antman","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib80","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1161\/01.CIR.90.4.1631","volume":"90","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib81","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.98.25.2805","article-title":"TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial","volume":"98","author":"Cannon","year":"1998","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib82","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.CIR.94.5.911","article-title":"for the TIMI 9B Investigators. Hirudin in acute myocardial infarction. Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial","volume":"94","author":"Antman","year":"1996","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib83","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199609123351103","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib84","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(01)05775-0","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib85","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1053\/euhj.2000.2498","volume":"21","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib86","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa060898","article-title":"Enoxaparin versus unfractionated heparin with fibrinolysis for ST- elevation myocardial infarction","volume":"354","author":"Antman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib87","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0002-9149(00)01505-8","article-title":"Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice","volume":"87","author":"Wienbergen","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib88","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2004.02.006","article-title":"Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project","volume":"148","author":"Huynh","year":"2004","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib89","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/01.CIR.95.11.2508","article-title":"Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction","volume":"95","author":"Berkowitz","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib90","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/oxfordjournals.eurheartj.a061905","article-title":"Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials","volume":"6","author":"Yusuf","year":"1985","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib91","first-page":"349","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib92","first-page":"871","volume":"2","year":"1987","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib93","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1161\/01.CIR.98.24.2659","article-title":"Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 Study","volume":"98","author":"Franzosi","year":"1998","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib94","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/bmj.316.7141.1337","article-title":"ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither","volume":"316","author":"Baigent","year":"1998","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0665_bib95","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0002-9149(94)90552-5","article-title":"A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction","volume":"74","author":"Granger","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib96","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/0735-1097(89)90399-9","article-title":"Improved thrombolysis with a modified dose regiment of recombinant tissue-type plasminogen activator","volume":"14","author":"Neuhaus","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib97","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0735-1097(92)90131-6","article-title":"Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction: rAAMI Study Investigators","volume":"20","author":"Carney","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib98","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0735-1097(92)90265-O","article-title":"Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)","volume":"19","author":"Neuhaus","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib99","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/0735-1097(94)90163-5","article-title":"Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial","volume":"24","author":"Cannon","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib100","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM199311253292204","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib101","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/oxfordjournals.eurheartj.a060126","volume":"13","year":"1992","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib102","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.CIR.94.6.1233","article-title":"One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) Trial","volume":"94","author":"Califf","year":"1996","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib103","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/01.CIR.91.7.1923","article-title":"Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion","volume":"91","author":"Simes","year":"1995","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib104","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/01.CIR.97.16.1549","article-title":"Extended mortality benefit of early postinfarction reperfusion","volume":"97","author":"Ross","year":"1998","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/01.CIR.82.3.781","article-title":"Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction","volume":"82","author":"Ohman","year":"1990","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib106","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/00019501-199311000-00002","article-title":"An analysis of the cause of early mortality after administration of thrombolytic therapy: the Thrombolysis Angioplasty in Myocardial Infarction Study Group","volume":"4","author":"Ohman","year":"1993","journal-title":"Coron Artery Dis"},{"key":"10.1378\/chest.08-0665_bib107","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0002-8703(98)70024-9","article-title":"An angiographic assessment of alteplase: double-bolus and front-loaded infusion regimens in myocardial infarction","volume":"136","author":"Bleich","year":"1998","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib108","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1161\/01.CIR.91.11.2725","article-title":"More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase (r-PA) compared with alteplase infusion in acute myocardial infarction","volume":"91","author":"Smalling","year":"1995","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib109","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.CIR.94.5.891","article-title":"Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction","volume":"94","author":"Bode","year":"1996","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib110","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/01.CIR.102.15.1761","article-title":"Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III trial","volume":"102","author":"Topol","year":"2000","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib111","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.CIR.95.2.351","article-title":"TNK-tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial","volume":"95","author":"Cannon","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib112","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0002-9149(99)00483-X","article-title":"Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial","volume":"84","author":"Gibson","year":"1999","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1378\/chest.08-0665_bib113","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0002-8703(99)70400-X","article-title":"Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial","volume":"137","author":"Van Dewerf","year":"1999","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib114","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0002-8703(03)00117-0","article-title":"One-year follow-up of the ASSENT-2 trial: a double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction","volume":"146","author":"Sinnaeve","year":"2003","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib115","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(00)02552-6","article-title":"Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis","volume":"356","author":"Mehta","year":"2003","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib116","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0140-6736(05)73310-9","article-title":"Intracranial haemorrhage with bolus thrombolytic agents [letter]","volume":"356","author":"Armstrong","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib117","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/jama.285.4.444","article-title":"Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials: intracranial hemorrhage in trials of bolus thrombolytic therapy","volume":"285","author":"Eikelboom","year":"2001","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib118","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(97)11198-9","article-title":"Failed coronary thrombolysis","volume":"351","author":"Davies","year":"1998","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib119","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1161\/01.CIR.93.11.1993","article-title":"Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction","volume":"93","author":"Ito","year":"1996","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib120","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/01.CIR.97.8.765","article-title":"Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction","volume":"97","author":"Wu","year":"1998","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib121","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0665_bib122","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9149(90)90833-M","article-title":"Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction","volume":"66","author":"Verheugt","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib123","first-page":"245","article-title":"Effects of intermittent treatment with aspirin on thromboxane and prostacyclin formation in patients with acute myocardial infarction","volume":"2","author":"Rasmanis","year":"1998","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib124","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9149(89)91085-0","article-title":"Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction","volume":"63","author":"Johannessen","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib125","first-page":"634","volume":"8","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib126","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/01.CIR.87.5.1524","article-title":"Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo- controlled angiographic study; results of the APRICOT Study","volume":"87","author":"Meijer","year":"1993","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib127","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/euhj.1999.1874","article-title":"Randomized comparative trial of triflusal and aspirin following acute myocardial infarction","volume":"21","author":"Cruz-Fernandez","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib128","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/oxfordjournals.eurheartj.a060564","article-title":"Ridogrel does not increase the speed and rate of coronary recanalization in patients with myocardial infarction treated with alteplase and heparin","volume":"15","author":"Tranchesi","year":"1994","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib129","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.89.2.588","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib130","first-page":"558","article-title":"Comparative trial of sulphinpyrazone and aspirin plus dipyridamole in acute myocardial infarction","volume":"34","author":"Misra","year":"1983","journal-title":"Curr Ther Res"},{"key":"10.1378\/chest.08-0665_bib131","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9149(97)89171-0","article-title":"A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction","volume":"77","author":"O'Connor","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib132","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib133","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib134","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2006.02.052","article-title":"The role of clopidogrel in early and sustained arterial patency after fibrinolysis for st-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study","volume":"48","author":"Scirica","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11239-007-0016-x","article-title":"Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28","volume":"24","author":"McLean","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"10.1378\/chest.08-0665_bib136","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib137","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"Early and late effects of clopidogrel in patients with acute coronary syndromes","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib138","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","article-title":"Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study","volume":"108","author":"Peters","year":"2003","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib139","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib140","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2005.10.047","article-title":"Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention","volume":"47","author":"Steinhubl","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib141","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2006.06.049","article-title":"Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting","volume":"48","author":"Cuisset","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib142","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2006.04.090","volume":"48","author":"Montalescot","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib143","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","author":"Sabatine","year":"2005","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib144","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bmj.313.7058.652","article-title":"Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials","volume":"313","author":"Collins","year":"1996","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0665_bib145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/hrt.67.2.122","article-title":"Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial","volume":"67","author":"De Bono","year":"1992","journal-title":"Br Heart J"},{"issue":"86(suppl)","key":"10.1378\/chest.08-0665_bib146","first-page":"I-259","article-title":"Infusion of heparin conjunct to streptokinase accelerates reperfusion of acute myocardial infarction: results of a double blind randomized study (OSIRIS) [abstract]","author":"Col","year":"1992","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib147","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0735-1097(94)90496-0","article-title":"A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: the Duke University Clinical Cardiology Study (DUCCS) 1","volume":"23","author":"O'Connor","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib148","first-page":"65","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib149","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM199703203361207","article-title":"Drug therapy: aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction","volume":"336","author":"Collins","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib150","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9149(97)89305-8","article-title":"Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy","volume":"77","author":"Mahaffey","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib151","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archinte.1991.00400020085018","article-title":"A standard heparin nomogram for the management of heparin therapy","volume":"151","author":"Cruickshank","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0665_bib152","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/0002-9149(90)90525-6","article-title":"Effect of heparin on coronay arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction","volume":"66","author":"Bleich","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib153","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJM199011223232101","article-title":"A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction","volume":"323","author":"Hsia","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib154","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1161\/01.CIR.90.4.1631","volume":"90","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib155","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.CIR.90.4.1624","volume":"90","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib156","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1161\/01.CIR.90.4.1638","article-title":"Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study","volume":"90","author":"Neuhaus","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib157","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.CIR.93.5.870","article-title":"Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial","volume":"93","author":"Granger","year":"1996","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib158","first-page":"279","article-title":"Efficacy and safety of two unfractionated heparin dosing regiments with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)","volume":"94","author":"Curtis","year":"2004","journal-title":"Am Heart J"},{"issue":"suppl","key":"10.1378\/chest.08-0665_bib159","first-page":"1725","article-title":"The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Hirsh","year":"2004","journal-title":"Chest"},{"key":"10.1378\/chest.08-0665_bib160","first-page":"782","article-title":"College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy","volume":"122","author":"Olson","year":"1998","journal-title":"Arch Pathol Lab Med"},{"issue":"suppl","key":"10.1378\/chest.08-0665_bib161","doi-asserted-by":"crossref","first-page":"489S","DOI":"10.1378\/chest.114.5_Supplement.489S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.08-0665_bib162","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ajcp\/89.1.19","article-title":"The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer","volume":"89","author":"Shojania","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"10.1378\/chest.08-0665_bib163","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1001\/archinte.1997.00440420107010","article-title":"Inability of activated partial thromboplastin time to predict heparin levels: time to reassess guidelines for heparin assays","volume":"157","author":"Baker","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0665_bib164","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-119-2-199307150-00002","article-title":"Establishing a therapeutic range for heparin therapy","volume":"119","author":"Brill-Edwards","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0665_bib165","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/01.CIR.83.5.1534","article-title":"A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction","volume":"83","author":"Thompson","year":"1991","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib166","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199207163270301","article-title":"Reactivation of unstable angina after the discontinuation of heparin","volume":"327","author":"Theroux","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib167","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1161\/01.CIR.91.7.1929","article-title":"Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes","volume":"91","author":"Granger","year":"1995","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib168","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","volume":"295","year":"2006","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib169","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0002-8703(92)90793-U","article-title":"The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty","volume":"123","author":"McGarry","year":"1992","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib170","first-page":"2","article-title":"The relation of clinical outcome to dissection and thrombus formation during coronary angioplasty","volume":"7","author":"Ferguson","year":"1995","journal-title":"J Invas Cardiol"},{"key":"10.1378\/chest.08-0665_bib171","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.CIR.93.4.667","article-title":"Relation between activated clotting time during angioplasty and abrupt closure","volume":"93","author":"Narins","year":"1996","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib172","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.103.7.961","article-title":"Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials","volume":"103","author":"Chew","year":"2001","journal-title":"Circulation"},{"issue":"126(suppl)","key":"10.1378\/chest.08-0665_bib173","doi-asserted-by":"crossref","first-page":"576S","DOI":"10.1378\/chest.126.3_suppl.576S","article-title":"Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","author":"Popma","year":"2004","journal-title":"Chest"},{"key":"10.1378\/chest.08-0665_bib174","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.0000139868.53594.24","article-title":"Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention","volume":"110","author":"Brener","year":"2004","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib175","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0735-1097(97)00495-6","article-title":"High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study","volume":"31","author":"Verheugt","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib176","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0735-1097(99)00597-5","article-title":"High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial","volume":"35","author":"Liem","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib177","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib178","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.289.3.331","article-title":"Use of low- molecular-weight heparins in the management of acute coronary syndromes and percutaneous coronary intervention","volume":"289","author":"Wong","year":"2003","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib179","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0735-1097(98)00612-3","article-title":"Low molecular weight heparin (dalteparin) as adjuvant treatment to thrombolysis in acute myocardial infarction: a pilot study; biochemical markers in acute coronary syndromes (BIOMACS II)","volume":"33","author":"Frostfeldt","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib180","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/hc3101.093866","article-title":"Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART-II)","volume":"104","author":"Ross","year":"2001","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib181","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/01.CIR.0000013402.34759.46","article-title":"Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 trial","volume":"105","author":"Antman","year":"2002","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib182","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/euhj.2001.3083","article-title":"Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction: the AMI-SK study","volume":"23","author":"Simoons","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib183","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0195-668X(03)00006-X","article-title":"Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction: the ASSENT Plus study","volume":"24","author":"Wallentin","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib184","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0735-1097(97)00258-1","article-title":"Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute myocardial infarction: the Fragmin in Acute Myocardial Infarction (FRAMI) Study","volume":"30","author":"Kontny","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib185","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0002-9149(96)00152-X","article-title":"Reduction of reinfarction and angina with use of low-molecular-weight heparin therapy after streptokinase (and heparin) in acute myocardial infarction","volume":"77","author":"Glick","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib186","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/euhj.2001.2940","article-title":"Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction","volume":"23","author":"Baird","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib187","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.293.4.427","volume":"293","year":"2005","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib188","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.0000081659.72985.A8","volume":"108","author":"Wallentin","year":"2002","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib189","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ahj.2004.08.033","article-title":"Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction","volume":"148","author":"Yusuf","year":"2004","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib190","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/hc3101.093866","article-title":"Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin-Second trial of heparin and aspirin reperfusion therapy (HART II)","volume":"104","author":"Ross","year":"2001","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib191","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0735-1097(03)01040-4","article-title":"The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial","volume":"42","author":"Cohen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib192","first-page":"81","article-title":"Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction","volume":"24","author":"Zhang","year":"2004","journal-title":"J First Mil Med Univ"},{"key":"10.1378\/chest.08-0665_bib193","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ahj.2003.12.028","article-title":"Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction","volume":"147","author":"Sinnaeve","year":"2004","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib194","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ahj.2006.07.005","article-title":"Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS","volume":"152","author":"Sinnaeve","year":"2006","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib195","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/eurheartj\/ehm081","article-title":"Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from EXTRACT-TIMI 25","volume":"28","author":"White","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib196","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","volume":"354","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib197","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1053\/euhj.2001.2777","article-title":"A synthetic factor-Xa inhibitor (ORG31540\/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction: the PENTALYSE study","volume":"22","author":"Coussement","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib198","first-page":"II-699","article-title":"Fondaparinux versus control (placebo or unfractionated heparin) as an adjunct to thrombolytic therapy in acute myocardial infarction: an OASIS 6 substudy","volume":"114","author":"Peters","year":"2006","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib199","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(02)07495-0","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib200","first-page":"I453","article-title":"Argatroban versus heparin as adjuvant therapy to thrombolysis for acute myocardial infarction: safety considerations: ARGAMI-2 study","author":"Behar","year":"1998","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib201","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0735-1097(99)00319-8","article-title":"Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial","volume":"34","author":"Neuhaus","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib202","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1161\/01.CIR.96.7.2155","article-title":"Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO)","volume":"96","author":"White","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib203","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199509213331204","article-title":"Treatment with bivalirudin (hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina","volume":"333","author":"Bittl","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib204","doi-asserted-by":"crossref","first-page":"43P","DOI":"10.1016\/S0002-9149(98)00766-8","article-title":"for the Hirulog Angioplasty Study Investigators. A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina","volume":"82","author":"Bittl","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib205","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1067\/mhj.2001.119374","article-title":"Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: final report reanalysis of the Bivalirudin Angioplasty Study","volume":"142","author":"Bittl","year":"2001","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib206","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199509213331203","article-title":"A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty","volume":"333","author":"Serruys","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib207","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1067\/mhj.2002.122173","article-title":"Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)","volume":"143","author":"Lincoff","year":"2002","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib208","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib209","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ahj.2005.09.007","article-title":"Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial","volume":"152","author":"Rajagopal","year":"2006","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib210","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jacc.2005.12.077","article-title":"A randomized trial to evaluate the relative protection against post- percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial","volume":"47","author":"Gibson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib211","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib212","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ccd.10276","article-title":"Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia","volume":"57","author":"Lewis","year":"2002","journal-title":"Cathet Cardiovasc Interv"},{"issue":"suppl","key":"10.1378\/chest.08-0665_bib213","first-page":"14F","article-title":"Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention","volume":"12","author":"Campbell","year":"2000","journal-title":"J Invas Cardiol"},{"key":"10.1378\/chest.08-0665_bib214","first-page":"611","article-title":"The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results","volume":"15","author":"Mahaffey","year":"2006","journal-title":"J Invas Cardiol"},{"key":"10.1378\/chest.08-0665_bib215","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.98.25.2829","article-title":"Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb\/IIIa integrin in ischemic heart disease","volume":"98","author":"Kong","year":"1998","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib216","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib217","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ehj.2004.09.018","article-title":"Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion: results of the Austrian multi-centre randomized ReoPro-BRIDGING Study","volume":"25","author":"Gyongyosi","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib218","first-page":"381","article-title":"Profound inhibition platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 pilot study","volume":"22","author":"Kleiman","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.08-0665_bib219","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.95.4.846","article-title":"Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb\/IIIa integrin receptor blockade with integrilin in acute myocardial infarction","volume":"95","author":"Ohman","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib220","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0735-1097(98)00474-4","volume":"32","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib221","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1053\/euhj.1999.2035","article-title":"Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction: a phase II dose escalation, randomized, double-blind study","volume":"21","author":"Ronner","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib222","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/01.CIR.99.21.2720","article-title":"Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial","volume":"99","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib223","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/euhj.2000.2243","article-title":"Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14","volume":"21","author":"Antman","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib224","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/01.CIR.101.24.2788","volume":"101","year":"2000","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0735-1097(01)01758-2","article-title":"Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial","volume":"39","author":"Brener","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib226","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0735-1097(03)00123-2","article-title":"Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the Integrilin and Tenecteplase in Acute Myocardial Infarction (INTEGRITI) phase II angiographic trial","volume":"41","author":"Giugliano","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib227","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(00)05059-5","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib228","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ehj.2003.07.004","article-title":"Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb\/IIIa inhibitor therapy in acute myocardial infarction: dichotomous response as a function of age in the GUSTO V trial","volume":"24","author":"Savonitto","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib229","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1001\/jama.288.17.2130","article-title":"Mortality at 1 year with combination platelet glycoprotein IIb\/IIIa inhibition and reduced-dose fibrinolytic therapy vs. conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial","volume":"288","author":"Lincoff","year":"2002","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib230","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.293.14.1759","article-title":"Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials","volume":"293","author":"De Luca","year":"2005","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib231","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.CIR.98.8.734","article-title":"Randomzed placebo-controlled trial of platelet glycoprotein IIb\/IIIa blockade with primary angioplasty for acute myocardial infarction: reoPro and Primary PTCA Organization and Randomized Trial (RAPPORT)","volume":"98","author":"Brener","year":"1998","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib232","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0735-1097(99)00635-X","article-title":"Effect of glycoprotein IIb\/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction","volume":"35","author":"Neumann","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib233","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","article-title":"Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction","volume":"344","author":"Montalescot","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib234","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mhj.2002.119762","article-title":"Abciximab improves 6-month clinical outcome after rescue coronary angioplasty","volume":"143","author":"Petronio","year":"2002","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib235","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0002-9149(02)02530-4","article-title":"Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty","volume":"90","author":"Zorman","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib236","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jacc.2003.07.017","article-title":"A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction","volume":"42","author":"Antoniucci","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib237","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0195-668X(02)00324-1","article-title":"Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty","volume":"24","author":"Petronio","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib238","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jacc.2005.11.018","article-title":"Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials","volume":"47","author":"De Luca","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib239","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","article-title":"Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction","volume":"344","author":"Montalescot","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib240","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1093\/eurheartj\/ehi620","volume":"26","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib241","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/01.CIR.86.6.1710","article-title":"A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction","volume":"86","author":"O'Neill","year":"1992","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib242","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/hrt.82.4.426","article-title":"Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study","volume":"82","author":"Vermeer","year":"1999","journal-title":"Heart"},{"key":"10.1378\/chest.08-0665_bib243","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0735-1097(99)00444-1","article-title":"A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial","volume":"34","author":"Ross","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib244","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/euhj.1999.1993","article-title":"Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory: the PRAGUE Study","volume":"21","author":"Widimsky","year":"2000","journal-title":"Eur Heart J"},{"issue":"suppl","key":"10.1378\/chest.08-0665_bib245","first-page":"33","article-title":"Primary versus facilitated percutaneous coronary intervention for acute ST-segment myocardial infarction: the final results of the GRACIA-2 randomized trial [abstract]","volume":"25","author":"Fernandez-Aviles","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib246","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(06)68147-6","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib247","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(06)68148-8","article-title":"Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials","volume":"367","author":"Keeley","year":"2006","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib248","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jacc.2005.04.042","article-title":"Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI Study)","volume":"46","author":"Le May","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"suppl","key":"10.1378\/chest.08-0665_bib249","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0195-668X(03)94640-9","article-title":"Prehospital versus periprocedural administration of abciximab in STEMI: early and late results from the randomised REOMOBILE study. [abstract]","volume":"24","author":"Arntz","year":"2003","journal-title":"Eur Heart J"},{"issue":"suppl","key":"10.1378\/chest.08-0665_bib250","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0195-668X(03)95631-4","article-title":"Early administration of abciximab bolus in the emergency room improves microperfusion after primary percutaneous coronary intervention, as assessed by TIMI frame count: results of the ERAMI trial [abstract]","volume":"24","author":"Mesquita Gabriel","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib251","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ehj.2004.04.003","article-title":"Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b\/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial","volume":"25","author":"Van't Hof","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib252","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/01.CIR.0000056120.00513.7A","article-title":"Adjunctive platelet glycoprotein IIb\/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the Tirofiban Given in the Emergency Room Before Primary Angioplasty (TIGER-PA) pilot trial","volume":"107","author":"Lee","year":"2003","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib253","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0002-9149(03)00983-4","article-title":"Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction","volume":"92","author":"Cutlip","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0665_bib254","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1093\/eurheartj\/ehi293","article-title":"Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial","volume":"26","author":"Zeymer","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2005.04.025","article-title":"Early abciximab administration in acute myocardial infarction treated with primary coronary intervention","volume":"108","author":"Bellandi","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1378\/chest.08-0665_bib256","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ahj.2006.06.003","article-title":"Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial","volume":"152","author":"Gibson","year":"2006","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib257","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ahj.2006.12.007","article-title":"Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: a randomized study","volume":"153","author":"Rakowski","year":"2007","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib258","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jacc.2006.12.036","article-title":"Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAX-AMI Trial)","volume":"49","author":"Maioli","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib259","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.291.8.947","article-title":"Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial","volume":"291","author":"Kastrati","year":"2004","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0665_bib260","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ahj.2005.04.005","volume":"150","year":"2005","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib261","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ahj.2003.07.025","article-title":"Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the facilitated intervention with enhanced reperfusion speed to stop events (FINESSE) trial","volume":"147","author":"Ellis","year":"2004","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0665_bib262","first-page":"357","article-title":"Rescue angioplasty during myocardial infarction has a beneficial effect on mortality: a tenable hypothesis","volume":"8","author":"Belenkie","year":"1992","journal-title":"Can J Cardiol"},{"key":"10.1378\/chest.08-0665_bib263","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.CIR.90.5.2280","article-title":"Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction","volume":"90","author":"Ellis","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0665_bib264","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jacc.2003.12.059","article-title":"A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit Infarction (MERLIN) trial","volume":"44","author":"Sutton","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib265","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMoa050849","article-title":"Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction","volume":"353","author":"Gershlick","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0665_bib266","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jacc.2006.03.064","article-title":"Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy","volume":"48","author":"Collet","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib267","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/hrt.2004.047753","article-title":"One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial","volume":"91","author":"Sutton","year":"2005","journal-title":"Heart"},{"key":"10.1378\/chest.08-0665_bib268","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0140-6736(92)91893-D","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0665_bib269","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0195-668X(03)00006-X","article-title":"Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction: the ASSENT Plus study","volume":"24","author":"Wallentin","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0665_bib270","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0735-1097(94)90003-5","article-title":"A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent: a Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-derived analysis","volume":"24","author":"Mauri","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0665_bib271","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMoa0706816","article-title":"Facilitated PCI in patients with ST-elevaton myocardial infarction","volume":"358","author":"Ellis","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369208601294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369208601294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T22:00:37Z","timestamp":1655935237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369208601294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":271,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0012369208601294"],"URL":"https:\/\/doi.org\/10.1378\/chest.08-0665","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}